Magneto-mechanical treatment of human glioblastoma cells with engineered iron oxide powder microparticles for triggering apoptosis.

In nanomedicine, treatments based on physical mechanisms are more and more investigated and are promising alternatives for challenging tumor therapy. One of these approaches, called magneto-mechanical treatment, consists in triggering cell death via the vibration of anisotropic magnetic particles, under a low frequency magnetic field. In this work, we introduce a new type of easily accessible magnetic microparticles (MMPs) and study the influence of their surface functionalization on their ability to induce such an effect, and its mechanism. We prepared anisotropic magnetite microparticles by liquid-phase ball milling of a magnetite powder. These particles are completely different from the often-used SPIONs: they are micron-size, ferromagnetic, with a closed-flux magnetic structure reminiscent of that of vortex particles. The magnetic particles were covered with a silica shell, and grafted with PEGylated ligands with various physicochemical properties. We investigated both bare and coated particles' in vitro cytotoxicity, and compared their efficiency to induce U87-MG human glioblastoma cell apoptosis under a low frequency rotating magnetic field (RMF). Our results indicated that (1) the magneto-mechanical treatment with bare MMPs induces a rapid decrease in cell viability whereas the effect is slower with PEGylated particles; (2) the number of apoptotic cells after magneto-mechanical treatment is higher with PEGylated particles; (3) a lower frequency of RMF (down to 2 Hz) favors the apoptosis. These results highlight a difference in the cell death mechanism according to the properties of particles used - the rapid cell death observed with the bare MMPs indicates a death pathway via necrosis, while PEGylated particles seem to favor apoptosis.

Pressure measurement evaluation and accuracy validation: the Gabarith test.

OBJECTIVE: The dynamic distortion introduced by manometric systems has been known for many years, with several methods developed to describe and quantify the degree of distortion. We developed the Gabarith as a technique to describe more accurately, and yet more simply, the dynamic accuracy of the chain of monitoring. SETTING: A pressure monitoring system transforms some input signal, i.e. the actual pressure waveform present in the artery, into some other shape of waveform, i.e. the waveform displayed on the patient monitor. This transformation is characterized by the transfer function of the total system. A complete technique to define the transfer function is to measure the response directly at many different frequencies and combine them to produce the dynamic response plot. METHOD: We described the dynamic response of a monitoring chain and we simplified the communication of this dynamic response to users by developing the Gabarith, as a tolerance envelope based on the frequency content of typical pressure waveforms. If a given monitoring chain's dynamic response (including a catheter, a pressure kit and a monitor) can be shown to fall within that tolerance envelope, the chain will provide adequate dynamic accuracy. CONCLUSION: "Gabarith tested" means that a pressure kit, in combination with a catheter and a monitor, has had its frequency response function measured and that the function falls within a tolerance band for dynamic accuracy. Passing a Gabarith means that a given level of accuracy will be reached when using the sets which have passed the corresponding test.

Hazardous information from bedside fast-flush device test for fluid-filled pressure monitoring systems.

The fast-flush device test--based on the square-wave principle--has been used in clinical practice to test the accuracy of fluid-filled pressure-monitoring systems. One assumption with the square-wave test is that the system is a second-order approximation. To elucidate the problem, the authors compared, in vitro, a reference test method (frequency response test), valid for second-order systems, with a pure square-wave test and a fast-flush device test. They showed that the two tested systems did not have any relation to the reference system, which suggests that the second-order approximation is not valid. Therefore, the fast-flush device test cannot be used reliably in testing the total chain of catheter, tubing, transducer, and monitor for invasive pressure measurement.